Literature DB >> 12095565

Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression.

Dirk Rades1, Fedor Heidenreich, Johann H Karstens.   

Abstract

PURPOSE: Metastatic spinal cord compression often requires urgent treatment selection, which could be facilitated by strong prognostic factors. Because only the type of primary tumor and pretreatment ambulatory status are known as prognostic factors for functional outcome, we investigated the prognostic value of the time of motor deficit development before radiotherapy (RT). METHODS AND MATERIALS: Ninety-eight patients were included between November 1998 and April 2000. Three subgroups were formed, according to time of motor deficit development before RT: 1-7 days (n = 31), 8-14 days (n = 31), and >14 days (n = 36). Ambulatory rates and motor function were evaluated for < or =24 weeks after RT. In a multivariate analysis, all three prognostic factors and radiation parameters were included.
RESULTS: In the >14-day subgroup, improvement occurred significantly (p < 0.001) more often than in the other subgroups (86% vs. 29% and 10%) and the posttreatment ambulatory rate was significantly higher (86% vs. 55% and 35%, p = 0.026). Multivariate analysis revealed the time of development of motor deficits before RT to be the strongest prognostic factor.
CONCLUSION: Functional outcome is significantly better with slower development of motor deficits before RT. This new, independent, prognostic factor must be considered in future trials aiming to define an optimal RT schedule.

Entities:  

Mesh:

Year:  2002        PMID: 12095565     DOI: 10.1016/s0360-3016(02)02819-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Clinical profile of long-term survivors of breast or thyroid cancer with metastatic spinal tumours.

Authors:  Y Kasai; E Kawakita; A Uchida
Journal:  Int Orthop       Date:  2006-04-26       Impact factor: 3.075

Review 2.  Malignant spinal cord compression.

Authors:  Madhuri Yalamanchili; Glenn J Lesser
Journal:  Curr Treat Options Oncol       Date:  2003-12

Review 3.  Metastatic epidural cord compression.

Authors:  Thomas N Byrne
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

4.  A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease.

Authors:  Paul Klimo; Clinton J Thompson; John R W Kestle; Meic H Schmidt
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

5.  Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?

Authors:  D Rades; S Huttenlocher; J N Evers; A Bajrovic; J H Karstens; V Rudat; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

Review 6.  Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature.

Authors:  Jaehon M Kim; Elena Losina; Christopher M Bono; Andrew J Schoenfeld; Jamie E Collins; Jeffrey N Katz; Mitchel B Harris
Journal:  Spine (Phila Pa 1976)       Date:  2012-01-01       Impact factor: 3.468

7.  Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression.

Authors:  M Ohashi; T Hirano; K Watanabe; K Katsumi; H Shoji; A Sano; H Tashi; I Takahashi; M Wakasugi; Y Shibuya; N Endo
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

Review 8.  Radiotherapeutic approaches to metastatic disease.

Authors:  Edward Chow; Jackson Wu; Andrew Loblaw; Carlos A Perez
Journal:  World J Urol       Date:  2003-08-09       Impact factor: 4.226

9.  DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).

Authors:  Rainer Souchon; Frederik Wenz; Felix Sedlmayer; Wilfried Budach; Jürgen Dunst; Petra Feyer; Wulf Haase; Wolfgang Harms; Marie-Luise Sautter-Bihl; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

10.  Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients.

Authors:  Laurens Bollen; Yvette M van der Linden; Willem Pondaag; Marta Fiocco; Bas P M Pattynama; Corrie A M Marijnen; Rob G H H Nelissen; Wilco C Peul; P D Sander Dijkstra
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.